← Back to Intel
Insider ActivityASND
JENSEN FLEMMING STEEN, See Remarks at Ascendis Pharma A/S, sold $4.6M of ASND
Updated Jun 14, 2026
JENSEN FLEMMING STEEN
See Remarks
Ascendis Pharma A/S ·
$ASND
Transaction Details
| Insider | JENSEN FLEMMING STEEN |
|---|---|
| Title | See Remarks |
| Company | Ascendis Pharma A/S |
| Ticker | ASND |
| Transaction Type | Sale |
| Transaction Date | 2026-05-11 |
| Shares Traded | 19,460 |
| Price Per Share | $238.4903 |
| Total Value | $4.6M |
| Filed Date | 2026-05-12 |
| Accession Number | 0001610717-26-000159 |
Ownership Context
| Shares Owned After Transaction | — |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001610717-26-000159
Other Insider Trades — ASND
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| SMITH SCOTT THOMAS | EVP & Chief Financial Officer | bought | $22K | 2026-06-02 |
| BIENAIME JEAN JACQUES | Insider | bought | $45K | 2026-05-29 |
| BIENAIME JEAN JACQUES | Insider | bought | $22K | 2026-05-29 |
| SMITH SCOTT THOMAS | EVP & Chief Financial Officer | bought | $56K | 2026-05-29 |
| BIENAIME JEAN JACQUES | Insider | bought | $47K | 2026-05-26 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ASND — Ascendis Pharma A/S →
Track ASND insider activity in real time on The Wire →
Get alerts when JENSEN FLEMMING STEEN files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 14, 2026 at 07:11 UTC